By
Motley Fool Contributors
|
More Articles
January 31, 2007
|
On Jan. 19, Biomet (Nasdaq: BMET ) released second-quarter earnings for the period ended Nov. 30.
- Net sales increased 5.2%, primarily driven by 9.4% growth in revenues from reconstructive products.
- Accounts receivable and inventory growth outpaced sales growth. That can be a troubling sign if it recurs several quarters in a row.
- On Dec. 18, the company announced that it would be taken off the market by a private equity group for $10.9 billion, or $44 per share in cash.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q2 2007
|
Q2 2006
|
Change
|
|
Sales
|
$520.3
|
$494.7
|
5.2%
|
|
Net Profit
|
$103.2
|
$101.3
|
1.9%
|
|
EPS
|
$0.42
|
$0.41
|
2.4%
|
|
Diluted Shares
|
245.1
|
249.3
|
(1.7%)
|
Get back to basics with a look at the income statement.
Margin Checkup
*Expressed in percentage points.
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
|
Assets
|
Q2 2007
|
Q2 2006
|
Change
|
|
Cash + ST Invest.
|
$105.0
|
$106.5
|
(1.4%)
|
|
Accounts Rec.
|
$554.3
|
$479.9
|
15.5%
|
|
Inventory
|
$563.2
|
$495.6
|
13.6%
|
|
Liabilities
|
Q2 2007
|
Q2 2006
|
Change
|
|
Accounts Payable
|
$56.9
|
$58.1
|
(2.1%)
|
|
Long-Term Debt
|
$0.0
|
$0.0
|
N/A
|
Learn the ways of the balance sheet.
Cash Flow Highlights
Find out why Fools always follow the money.
Related Companies:
-
Medtronic (NYSE: MDT )
-
Zimmer Holdings (NYSE: ZMH )
-
St. Jude Medical (NYSE: STJ )
-
Smith & Nephew (NYSE: SNN )
-
Varian Medical Systems (NYSE: VAR )
Related Foolishness:
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.